Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

APC and ACHC — the Accreditation Commission for Health Care — have renewed their partnership, pledging a commitment to advancing the role compounding pharmacies play in communities across the country.

“We continue to see PCAB accreditation as the gold standard for compounding pharmacies,” said APC CEO Scott Brunner, cae. “That’s why we’re delighted to partner with ACHC to encourage compounders to undertake accreditation as a means of demonstrating integrity and adherence to the Compounder Code of Ethics.”

The main benefit of the partnership is a $1,000 discount on PCAB accreditation for APC Pharmacy/Facility members. That new member type will be launched at the Owner Summit in Scottsdale later this month.